Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece

Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary... Clin Drug Investig (2017) 37:833–844 DOI 10.1007/s40261-017-0540-1 ORIGINAL RESEARCH ARTICLE Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece 1 2 3 4 • • • • George Gourzoulidis Georgia Kourlaba John Kakisis Mitiadis Matsagkas 5 6 7 • • • George Giannakoulas Konstantinos I. Gourgoulianis Theodoros Vassilakopoulos Nikos Maniadakis Published online: 12 June 2017 Springer International Publishing Switzerland 2017 Abstract with enoxaparin followed by dose-adjusted vitamin-K Background and Objective Venous thromboembolism antagonists for the treatment of DVT and PE in Greece. (VTE), comprising deep-vein thrombosis (DVT) and pul- Methods An existing Markov model was locally adapted monary embolism (PE), is a major healthcare concern that from a third-party payer perspective to reflect the man- results in substantial morbidity and mortality with great agement and complications of DVT and PE in the course of economic burden for healthcare systems. Hence, the need 3-month cycles, up to death. The clinical inputs and utility for effective and efficient treatment of patients with VTE is values were extracted from published studies. Direct important for both clinical and economic reasons. The medical costs, obtained from local resources, were incor- objective of this study was to evaluate the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Drug Investigation Springer Journals

Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece

Loading next page...
 
/lp/springer_journal/cost-effectiveness-analysis-of-rivaroxaban-for-treatment-of-deep-vein-pgzR0VmbJ8
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
1173-2563
eISSN
1179-1918
D.O.I.
10.1007/s40261-017-0540-1
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial